Drugs, genes and screens: the ethics of preventing and treating spinal muscular atrophy by Gyngell, C, Stark, Z, Savulescu, J

Rapid challenges: ethics and genomic neonatal intensive care by Gyngell, C, Stark, Z, Newsond, A, Wilkinson, D, Savulescu, J

Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration. by Amyes, E, Curnow, J, Stark, Z, Corlett, L, Sutton, I, Vincent, A

Intensive care clinicians’ perspectives on ethical challenges raised by rapid genomic testing in critically ill infants by Poogoda, S, Lynch, F, Stark, Z, Wilkinson, D, Savulescu, J, Vears, D, Gyngell, C

Exploring the benefits, harms, and costs of genomic newborn screening for rare diseases by Baple, EL, Scott, RH, Banka, S, Buchanan, J, Fish, L, Wynn, S, Wilkinson, D, Ellard, S, MacArthur, DG, Stark, Z

Australian public perspectives on genomic newborn screening: which conditions should be included? by Lynch, F, Best, S, Gaff, C, Downie, L, Archibald, AD, Gyngell, C, Goranitis, I, Peters, R, Savulescu, J, Lunke, S, Stark, Z, Vears, DF

A call to action to scale up research and clinical genomic data sharing by Stark, Z, Glazer, D, Hofmann, O, Rendon, A, Marshall, CR, Ginsburg, GS, Lunt, C, Effingham, M, Hastings Ward, J, Hill, SL, Ali, R, Goodhand, P, Page, A, Rehm, HL, North, KN, Allen, N, Scott, RH

Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 Microduplications. by Wincent, J, Bruno, D, van Bon, B, Bremer, A, Stewart, H, Bongers, E, Ockeloen, C, Willemsen, M, Keays, D, Baird, G, Newbury, D, Kleefstra, T, Marcelis, C, Kini, U, Stark, Z, Savarirayan, R, Sheffield, L, Zuffardi, O, Slater, H, de Vries, B, Knight, S, Anderlid, B, Schoumans, J